Literature DB >> 1551520

Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans.

B Cryer1, J S Redfern, M Goldschmiedt, E Lee, M Feldman.   

Abstract

The effect of aging on gastric and duodenal mucosal prostaglandins has not been reported. Gastric and duodenal mucosal prostaglandin concentrations were measured in 46 healthy adults, 35 of whom were relatively young (21-40 years old) and 11 of whom were considerably more elderly (aged 52-72 years). Mucosal biopsy specimens were obtained endoscopically from the fundus, antrum, duodenal bulb, and postbulbar duodenum, and extracts were assayed for prostaglandin F2 alpha and E2 concentrations by radioimmunoassay. Older age was associated with significantly lower fundic, antral, and post-bulbar duodenal prostaglandin concentrations. A second experiment was performed in 20 additional subjects (9 younger, 11 older) to determine whether lower mucosal concentrations in older subjects were reproducible and, if so, whether reduced gastric mucosal prostaglandins would have a physiological counterpart, namely increased gastric acid secretion. As in the original experiment, fundic, antral, and postbulbar mucosal prostaglandin levels were significantly lower in older subjects than in younger subjects. Mean basal acid output was significantly higher in older than younger subjects (9.8 +/- 2.5 vs. 4.8 +/- 1.6 mmol/h). It is concluded that gastric and duodenal prostaglandin concentrations decline with aging in humans and that the decline in fundic mucosal prostaglandins is associated with an increase in gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551520

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

Review 1.  Ageing and the gut.

Authors:  A L D'Souza
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

Review 2.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  The aging stomach: implications for NSAID gastropathy.

Authors:  M Lee; M Feldman
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

Review 4.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 5.  Increased susceptibility of aging gastric mucosa to injury: the mechanisms and clinical implications.

Authors:  Andrzej S Tarnawski; Amrita Ahluwalia; Michael K Jones
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 6.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

7.  Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection.

Authors:  Hui-Chao Wu; Bi-Guang Tuo; Wei-Min Wu; Yuan Gao; Qing-Qing Xu; Kui Zhao
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

8.  Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.

Authors:  P-I Hsu; K-H Lai; G-H Lo; H-H Tseng; C-C Lo; H-C Chen; W-L Tsai; H-S Jou; N-J Peng; C-H Chien; J-L Chen; P-N Hsu
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Tissue concentrations and correlations of prostaglandins in healthy and inflamed human esophageal and jejunal mucosa.

Authors:  K Tihanyi; I Rózsa; J Banai; I Dobó; A Bajtai
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

Review 10.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.